02361 SINOHEALTH HLDG
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 7.23X | Oper Margin | 29.9% |
|---|---|---|---|
| LT Debt/Equity | 1.0% | Net Margin | 27.4% |
| Total Debt/Equity | 1.7% | Return on Equity | 15.6% |
| Price/Book | 2.06X | Return on Assets | 13.7% |
| (HKD 3.440) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 117.68 | 112.46 | 62.52 | 96.40 | 80.61 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +4.6 | +79.9 | -35.2 | +19.6 | +28.6 |
| Earnings Per Share (HKD) | 0.287 | 0.264 | 0.152 | 0.258 | N/A |
| Earnings Per Share Growth (%) | +8.7 | +73.4 | -41.1 | +100.0 | N/A |
| Dividend Per Share (HKD) | 0.216 | 0.073 | 0.040 | No dividend | No dividend |
| P/E* (X) | 11.99 | 13.04 | 22.60 | 13.32 | N/A |
| Yield (%) | 6.27 | 2.11 | 1.16 | N/A | N/A |
| Dividend Share (%) | 75.22 | 27.47 | 26.15 | N/A | N/A |
| Book NAV (HKD) | 1.673 | 1.716 | 1.725 | N/A | N/A |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 403.728 | 396.194 | +1.9 | 356.668 |
| Operating Result | 120.148 | 110.741 | +8.5 | 54.273 |
| Associates | 0 | 0 | N/A | 0 |
| Profit Before Taxation | 120.148 | 110.741 | +8.5 | 54.474 |
| Taxation | 8.325 | 9.801 | -15.1 | 0.261 |
| Profit /( Loss) After Taxation | 111.823 | 100.94 | +10.8 | 54.213 |
| Minority Interests | 1.174 | -1.092 | -207.5 | -1.545 |
| Net Profit | 110.649 | 102.032 | +8.4 | 55.758 |
| Earnings Per Share () | 0.2869 | 0.2639 | +8.7 | 0.1522 |
| Dividend Per Share () | 0.2158 | 0.0725 | +197.7 | 0.0398 |
| Announcement Date | 2025-03-28 | 2024-03-28 | NA | 2023-03-29 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
